Lung cancer screening with low-dose computed tomography can reduce death from lung
cancer by 20–24% in high-risk smokers. National lung cancer screening programmes have …

Randomised clinical trials have shown the efficacy of computed tomography lung cancer
screening, initiating discussions on whether and how to implement population‐based …

Background Lung cancer is a major health problem. CT lung screening can reduce lung
cancer mortality through early diagnosis by at least 20%. Screening high-risk individuals is …

Background The NLST reported a significant 20% reduction in lung cancer mortality with
three annual low-dose CT (LDCT) screens and the Dutch-Belgian NELSON trial indicates a …

Abstract Introduction Low-dose CT (LDCT) screening reduces lung cancer specific mortality.
Several countries, including the UK, are evaluating the clinical impact and cost-effectiveness …

Lung cancer accounts for an alarming human and economic burden in low-and middle-
income countries (LMICs). Recent landmark trials from high-income countries (HICs) by …

Lung cancer is the leading cause of cancer death worldwide. The absence of symptoms in
early-stage (I/II) disease, when curative treatment is possible, results in> 70% of cases being …

Background Screening for lung cancer with low radiation dose computed tomography
(LDCT) has a strong evidence base. The European Council adopted a recommendation in …

Background: Existing challenges of lung cancer screening included non-accessibility of
computed tomography (CT) scanners and inter-reader variability, especially in resource …

Lung cancer is the number one cause of cancer death worldwide. The benefits of lung
cancer screening to reduce mortality and detect early‐stage disease are no longer in any …